《大行報告》花旗上調港交所(00388.HK)目標價至430元 評級「買入」
花旗發表研究報告,指出港交所(00388.HK)將會在11月11日公布第三季業績,預期第三季的純利為31.6億元,按季升6%及按年升43%,主要是受到本季的強勁現金交易量所帶動。
該行指,第三季的現金日均成交量按季增長24%及按年增長83%,至1,410億元,受惠於大型中概股回歸及南向交易量飆升。北向的交易量按季上升56%,按年上升135%,預期現金收入按季36%至11.7億元,按年升84%。
該行將港交所目標價由原來的425元上調至430元,今年的日均成交量預測為1,200億元,意味第四季的成交為1,000億元。重申「買入」投資評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.